Literature DB >> 7181476

Comparison of ceforanide and cephalothin prophylaxis for vaginal hysterectomies.

J A Jacobson, R Hebertson, E Kasworm.   

Abstract

We compared the safety and efficacy of a six-dose regimen of cephalothin with a two-dose regimen of ceforanide for the prevention of infection after elective vaginal hysterectomy. A total of 150 patients were randomly assigned to either regimen. The overall incidence of documented pelvic infection was 5.3% and did not differ significantly between the prophylaxis groups when stratified by type of surgery. No serious adverse reactions were encountered in either group, but phlebitis was significantly more common in patients receiving cephalothin. We conclude that a two-dose regimen of ceforanide given intramuscularly is as effective as, and possibly better tolerated than, a six-dose regimen of cephalothin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181476      PMCID: PMC183807          DOI: 10.1128/AAC.22.4.643

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Perioperative antibiotics in major elective gynecologic surgery.

Authors:  J F Holman; J E McGowan; J D Thompson
Journal:  South Med J       Date:  1978-04       Impact factor: 0.954

2.  Use of antimicrobial drugs in general hospitals: patterns of prophylaxis.

Authors:  M Shapiro; T R Townsend; B Rosner; E H Kass
Journal:  N Engl J Med       Date:  1979-08-16       Impact factor: 91.245

3.  Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy.

Authors:  W J Ledger; R L Sweet; J T Headington
Journal:  Am J Obstet Gynecol       Date:  1973-03-15       Impact factor: 8.661

4.  Prophylactic antibiotics for vaginal hysterectomies.

Authors:  D R Bolling; G D Plunkett
Journal:  Obstet Gynecol       Date:  1973-05       Impact factor: 7.661

5.  The prophylactic use of Keflex and Keflin in vaginal hysterectomy.

Authors:  M D Bivens; J Neufeld; W D McCarty
Journal:  Am J Obstet Gynecol       Date:  1975-05       Impact factor: 8.661

6.  Prophylactic antibiotics in gynecologic surgery.

Authors:  J H Grossman; T P Greco; M J Minkin; R L Adams; W J Hierholzer; V T Andriole
Journal:  Obstet Gynecol       Date:  1979-05       Impact factor: 7.661

7.  Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy.

Authors:  J Mendelson; J Portnoy; J R De Saint Victor; M M Gelfand
Journal:  Obstet Gynecol       Date:  1979-01       Impact factor: 7.661

8.  Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.

Authors:  F H Lee; M Pfeffer; D R Van Harken; R D Smyth; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Ceforanide: in vitro and clinical evaluation.

Authors:  K H Burch; D Pohlod; L D Saravolatz; T Madhavan; D Kiani; E L Quinn; R Del Busto; J Cardenas; E J Fisher
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

  9 in total
  2 in total

Review 1.  Antibiotic prophylaxis for elective hysterectomy.

Authors:  Reuben Olugbenga Ayeleke; Selma Mourad; Jane Marjoribanks; Karim A Calis; Vanessa Jordan
Journal:  Cochrane Database Syst Rev       Date:  2017-06-18

Review 2.  Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D M Campoli-Richards; T E Lackner; J P Monk
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.